Journal of Heart and Lung Transplantation

Article	Citations
Factors Associated with Prolonged Length of Stay After Pediatric Heart Transplantation	450
Methods and Preliminary Results of Implementation of Multi-Center Earlyimpella® Support in Patients with St-Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock (RECOVER IV) Trial	203
Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients	93
Machine Learning Models as an Accurate Predictor of Survival in Pediatric Heart Transplant	91
Lung Transplant Using Extra-Corporeal Membrane Oxygenation: Outcomes and Predictors of Conversion to Cardiopulmonary Bypass	89
Evaluation of Pulmonary Vasodilator Efficacy in LVAD Patients Using Invasive Right Heart Catheter Stress Testing	89
Waitlist Mortality for Patients with Cardiac Allograft Vasculopathy Under the 2018 UNOS Donor Heart Allocation System	88
Micro-RNA Biomarkers of Allograft Rejection in Pediatric Heart Transplantation	82
Genome-Wide DNA Methylation Profiling in Human Dilated Cardiomyopathy	70
Long Term Use of Implantable Left Ventricular Assist Devices in Pediatric Patients	65
Comparison Between Waiting List Diagnosis for Lung Transplantation for Pulmonary Interstitial Disease and Explant Analysis from the Largest Lung Transplantation Group of Brazil	60
Older Donor Hearts for Heart Transplantation	59
Early Onset Malignancy in the First-Year After Heart Transplantation	59
Impact of Preoperative Left Ventricular Ejection Fraction on Outcomes After Pulmonary Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension	57
WITHDRAWN	57
Comparative Analysis of Fontan Transplant Outcomes	56
Recurrent Migration of a Protekduo Right Ventricular Assist Device: A Case Report	54
Utilization of Distressed Communities Index to Examine the Impact of Socioeconomic Status on Left Ventricular Assist Device Outcomes	54
Out-Of-Hospital Cardiac Arrest Donor (OHCAd) Hearts: A Single-Center Experience	52
Assessing a Conservative Anticoagulation Protocol Following Gastrointestinal Bleeding in Patients with a HeartMate 3 LVAD	52
When to Wait, When to Act: A Single-Center Retrospective Review of Patients with Advanced Lung Disease Deemed 'Too Early' to List for Lung Transplantation	51
Donor Derived Cell Free DNA is a Reliable Marker in High Risk Heart Transplant Patients	49
Pulseless Paradoxus in a Heartmate3 Recipient with Cardiac Tamponade	48
Title: Clinical Outcomes of Lung Transplant Recipients with Myelodysplastic Syndrome and Short Telomere Syndrome	46
Impact and Outcomes of Hepatitis C Viremic Donors (HCV-NAAT) on Donor-Derived Cell-Free DNA Levels and Gene-Expresion Profiling (GEP-Allomap) in Heart Transplant Recipients	46

Extended Hypothermic Cardiac Preservation Using the VP.S ENCORE® Device Leads to Enhanced Cardiac Function in a Pilot Orthotopic Porcine Heart Transplant Study	44
Association of Neighborhood-Level Social Disinvestment with Worse Survival After Lung Transplant is Mediated by Individual Insurance Status	44
Utility of Breath Volatomic Analysis in Lung Transplant Recipients	44
A High Pulmonary-to-Systemic Arterial Elastance Ratio is a Powerful Predictor of Poor Outcomes After Heart Transplantation: A Clinical Study with Physiological Insights from Digital Twin Models	42
Single Cell Analysis of Bronchiolar Brushings Identifies Basal Cell Loss in CLAD	42
Outcomes of Lung Transplantation for Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation Compared with Interstitial Pulmonary Fibrosis	41
Plasma Proteins Ameliorate Loss of Coronary Vascular Resistance During Working Mode Normothermic Ex-Situ Heart Perfusion	40
Disseminated Mycobacterium Tuberculosis Post Lung Transplantation	40
Heart Transplant in Transthyretin Cardiac Amyloidosis: A Single-Center Experience	39
MINIMALLY INVASIVE PULMONARY ENDARTERECTOMY THROUGH INVERTED-T UPPER HEMISTERNOTOMY	37
Contemporary outcomes of mechanical circulatory support using paracorporeal continuous flow pump in children: A report from the ACTION learning network	37
INOPERABLE CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION:EVOLUTION OF PROGNOSIS IN 10 YEARS OF NEW EMERGING THERAPIES	37
Going the distance: Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial	36
Primary graft dysfunction, dysbiosis, and innate immune activation after lung transplantation	36
Ex-vivo lung perfusion: National trends and post-transplant outcomes	35
Safety of Erythropoiesis-Stimulating Agents for Pediatric Berlin EXCOR VAD Patients	34
Exercise Test and Hemodynamic Outcomes in Heart Transplant Patients Treated with Long-Term Mechanical Circulatory Support as Bridge to Transplantation	34
Amyloid Unmasked: A Rare Case of Apolipoprotein A- IV Cardiac Amyloidosis	34
Extent of Pulmonary Vascular Resistance Reduction with Temporary Mechanical Circulatory Devices Among Patients Awaiting Cardiac Transplantation	33
Organ Care System (OCS) Perfusion Time During Donation After Circulatory Death (DCD) Heart Transplantation: Not Too Little, Not Too Much: There Safety Lie	32
Evaluation of Platelet Activation by Flow Cytometry in Contemporary Continuous Flow Left Ventricular Assist Device Support	32
Living-Donor Single-Lobe Lung Transplantation: A Single-Center Case Series	32
Cardiac Tamponade Associated to an Early EBV-Induced Lymphoma After Heart Transplantation: A Case Report	31
Recurrence of pulmonary arterial hypertension 32 months after bilateral lung transplant	31
The impact of cardiovascular and lung comorbidities in patients with pulmonary arterial hypertension: A systematic review and meta-analysis	30
First North American Experience with The Berlin Heart Active Driver	30
Pediatric Heart Transplantation in Donation After Circulatory Death Using Normothermic Regional Perfusion - Early Experience with Small Donors	30
MTHFD2 ablation in T cells protects against heart transplant rejection by perturbing IRF4/PD-1 pathway through the metabolic-epigenetic nexus	30
Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Acute Decompensated Heart Failure	29
Global Outcomes with Extended Criteria Donors When Preserved at 4-8°C: An Updated Analysis of the International GUARDIAN Heart Registry	29
Extending the bridge, bridging the gap	29
Blockade of BLyS inhibits B-cell responses and antibody production for the prevention of chronic transplant rejection	29
Molecular criteria for pulmonary antibody-mediated rejection are associated with an increased risk of allograft failure	29
Mollicute Infections in Lung Transplant Patients: A Retrospective Review of Recipient Infections Post Initiation of a Screening Protocol	29
Outcomes in Children Supported with Paracorporeal Continuous Compared to Paracorporeal Pulsatile Ventricular Assist Devices	28
Conversion from Immediate Release Tacrolimus to LCP-Tacrolimus in Heart Transplant Recipients	28
The Use of Ambulatory Blood Pressure Monitoring in Pediatric Heart Transplant Recipients	27
Immunologic Outcomes Following Mycophenolate Dose Reduction in Lung Transplant Recipients	27
Letermovir Use for Cytomegalovirus Prophylaxis in Lung Transplant Recipients	27
Outcomes After Heart Transplantation from Donors After Circulatory Death versus Brain Death: A Systematic Review and Meta-Analysis	27
Acute Myocarditis: Trying to Dissect Potential Prognostic Factors	26
Pharmacist Managed Timing of Peri-Operative Plasmapheresis and Anti-Thymocyte Globulin in Heart Transplantation	26
SRC Homology and Collagen (Shc) Inhibition: A Novel Therapeutic Strategy for Transplant-Related Pulmonary Fibrosis	26
Sternal Closure After Clamshell Thoracotomy for Bilateral Lung Transplantation: Comparison Between Different Techniques	26
Early Outcomes from the Use of Thoracic Epidural Analgesia versus INC Cryoablation during Lung Transplantation - A Single Center Experience	26
Impact of Donor Transfusions on Lung Transplant Outcomes: A National Cohort Analysis	25
Post Transplant Malignancy Risk Factors in Thoracic Solid Organ Transplant Recipients	25
Single Nuclei Transcriptomic Analysis of Heart Allograft Ischemia-Reperfusion in a Rat Model	25
An Uncommon Driver of Waitlist Urgency: Recurrent Secondary Spontaneous Pneumothoraces of the Lung Allograft in a Single Lung Transplant (SLT) Recipient with CLAD	25
Influence of Risk Factors on PTLD-Free Probability in Lung Transplant Patients: SRTR Database Analysis	25

Activation of cGAS-Dependent Necroptosis during Cold Static Preservation of Lungs Relies on Calcium	25
Use of Heart in Donor Death Caused by Lightning	25
A Single Centre Review of INR Monitoring in Patients Implanted with HeartMate 3 Ventricular Assist Device	25
Effect of Heparin Coated ECMO Circuit on AntiPF4 Antibodies	24
A Bold Look: Evaluation of Skeletal Muscle Microvascular Function in Pediatric Heart Transplant Recipients Using Post-Contractile Blood Oxygen Level Dependent MRI	24
Donor Factors Contributing to the Increase in Adult Heart Transplant Volume in the United States	24
End Stage Heart Failure in Systemic Sclerosis- From Mechanical Circulatory Support to Heart Transplant	24
Evaluating age-based eligibility thresholds for heart re-transplantation – an analysis of the united network for organ sharing database	24
Midterm Outcomes in Orthotopic Heart Transplant Recipients with a History of Methamphetamine Use	24
Extending the Transplant Practitioner Role within the National Organ Retrieval Team to Include Organ Care Practitioner	23
Information for Readers	23
Information for Readers	23
Alveolar macrophage subsets: Accessories to lung alloimmune rejection	23
Hemodynamic Modeling for Mitral Regurgitation	23
(911) Older Donors in Lung Transplantation: The Portuguese Experience	23
(904) Early Weight Gain During Ex Vivo Lung Perfusion Can Predict Transplant Suitability and Post-Transplant Outcomes	23
Table of Contents	23
(854) Effect of Dobutamine on Rv Contractility and Rv-Pa Coupling in the Normal Rv	22
Pulmonary Hypertension and Diastolic Heart Failure in an Adolescent African-American Cantú Syndrome Patient	22
Oral Aversion and Its Risks in Pediatric Heart Transplant Recipients	22
Use of a Medication Questionnaire to Identify Lung Transplant Recipients Benefiting from Pharmacist Prioritization in Clinic	22
Using Donor Lungs ≥70 Years of Age for Transplantation - Do Long-Term Outcomes Justify the Use?	22
(1033) Effect of Practice Variation Amongst Organ Procurement Organizations on Pediatric Donor Heart Utilization	22
(908) Does Donor-Recipient Sex Mismatch Have an Influence on Long Term Outcomes after Lung Transplantation? An Experience of a High Volume Center	21
(849) The Utility of Mechanical Circulatory Support in the Management of Massive Pulmonary Embolism with Right Ventricular Failure	21
Bedside Ultrasound of Internal Jugular Vein for Right Ventricular Function Assessment	21
Argon Inhalation Reduces Pulmonary Ischemia-Reperfusion Injury in MHC-inbred CLAWN Miniature Swine	21
(1215) Think Inside The Box: Constrictive Pericarditis after Pediatric Lung Transplant	21
(811) Incidence of Right Ventricular Dysfunction in Lvad Patients Bridged with High Dose Inotropes	21
Hemodynamic Implications of Sildenafil in Candidates for Heart Transplantation with Group 2 Pulmonary Hypertension: A Single Latin-American Center Registry	21
Hypogammaglobinemia in Patients Palliated with the Fontan Circulation: Implications for Cardiac Transplantation	21
(120) Heart Preservation with the Organ Care System in Extended Criteria Donor Hearts: A Single Center Experience	21
When a Single Choice Impacts a Single Ventricle: Paracorporeal Pediatric VAD Support at 544 Days	21
(1206) Clinical Implications of Microbiome on Acute Rejection in Lung Transplant Recipients	20
(797) Implantation from Short Term MCS to Durable VAD: Single Center Experience	20
(151) Plasma Proteomic Signature of Human Heart Transplant Recipients After Restoration of Blood Circulation and Its Relationship to Graft Outcome	20
(782) Use of Extracorporeal Membrane Oxygenation in Ranolazine Overdose	20
(1188) Assessment of Dd-cfDNA Between Stable Single and Double Lung Recipients	20
ISHLT 2023 Author Index	20
(742) Prognostic Value of Donor Specific Human Leukocyte Antibodies in Pre-Sensitized Heart Transplant Patients	20
(1226) Serum Proteomics for Fibrotic Markers in Early Detection of Bronchiolitis Obliterans Syndrome after Lung Transplantation	20
(384) Urine Exosomes for Kidney Health Assessment in Mechanical Circulatory Support	20
Imaging Mass Cytometry for Detailed Cellular and Spatial Characterization of Chronic Lung Allograft Dysfunction (CLAD)	19
Predictors of One-Year Outcome in Patients Undergoing Cardiac Re-Transplantation: Machine Learning Analysis	19
Early Mammalian Target of Rapamycin Inhibitor Utilization After Heart Transplantation: Analysis of the UNOS Database	19
Immune Characterization of a Xenogeneic Cross Circulation System for Ex Vivo Human Lung Support	19
The Normalised Acute Rejection Score in the First Year Post Transplant and Its Association with CLAD	19
What's in a name: The importance of lung transplant at Cystic Fibrosis Foundation Accredited Care Centers for patients with Cystic Fibrosis	19
(888) Initiating an ECMO Program at a Safety Net Hospital During a Global Pandemic	19
Comparison of LVAD Admissions Before and During the Era of COVID-19	18
(472) Giant Cell Myocarditis with LVAD Presenting with Acute Severe AI Managed with Valve-In-Valve TAVI	18
(715) Diaphragm Dysfunction from Covid-19 Phrenic Neuropathy: Utilization of Diaphragm Pacing for Recovery	18
(1270) Thermal Preconditioning During EVLP Reduces T Lymphocytes and Increases Monocytes and Neutrophils Contents in the Perfusion Solution	18
Predictors of Failure to Rescue After Left Ventricular Assist Device Implantation	18
Ventricular Arrhythmias and Implantable Cardioverter-Defibrillator Use in Patients with Left-Ventricular Assist Device: Validation of the VT-LVAD Prediction Score	18
Challenges in Heart Transplantation During COVID-19 Pandemic in Brazil	18
Sequential Double-Lung Transplantation in Kartagener Syndrome: A Case Report	18
Heart Transplantation Utilizing Organs Following Donation After Circulatory Death (DCD)	18
Polymicrobial and Multiple Blood Stream Infection Episodes as Risk Factors for On-Pump Mortality in Mechanical Circulatory Support Patients	18
Decoupling Between Pulmonary Artery Diastolic and Wedge Pressure Following TAVR	18
Safety of Single Lung Transplantation Post Donation Service Area-Specific Organ Distribution	18
(1153) Characterization of CD3-Guided Anti-Thymocyte Globulin Dose Minimization for Renal Sparing Induction after Heart Transplant	18
Kidney Transplantation in Single Ventricle Palliated Patients: A Pediatric Cardiac Care Consortium Study	18
Extra-cardiac management of cardiogenic shock in the intensive care unit	17
Sotrovimab in pediatric cardiac transplant recipients with SARS-CoV2 infection	17
Comparing the Outcomes of Combined Heart-Liver Transplant Recipients from DCD and Non-DCD Donors: An Analysis Using the UNOS Database	17
Social Determinants of Health, Race and Their Relationship to Time in Therapeutic INR Range Following LVAD Implantation	17
Duration of Donor Cardiac Downtime in Donors After Circulatory Death Transplant	17
Optimizing the handling of missing data in the UNOS database	17
The evaluation of constant coronary artery flow versus constant coronary perfusion pressure during normothermic ex situ heart perfusion	17
(324) Stanford Pediatric Psychosocial Optimization Tool for Transplant	17
Lung Transplantation for Primary Ciliary Dyskinesia - A Single Center Review	17
Impact of Logistic Challenges on Cardiac Transplantation	17
Improved Oxygenation and Atelectasis in Brain-Dead (BD) Donors with a Novel Percutaneous Transvenous Phrenic Nerve Stimulator	17
Cardiac output assessment methods in left ventricular assist device patients: A problem of heteroscedasticity	17
Daratumumab monotherapy as a desensitization strategy prior to cardiac transplantation	17
Backwash Maneuver in LVAD Inflow Thrombosis: A Single-Center Experience (2015-2024)	17
Cold Blood Cardioplegia Use for Cardiac Arrest After Heart Transportation with Organ Care System May Improve Outcomes	17
Survival After Combined Lung and Liver Transplantation: A 22-year Single-Centre Retrospective Study	17
Early Detection of Baseline Lung Allograft Dysfunction: The Concept of Pre-BLAD	16

Lactic Acid and Metabolic Analysis of Human Donor Hearts Preserved with Organ Care System	16
Lung Transplantation from hepatitis C+ donor lungs: Reassuring midterm outcomes	16
Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation	16
Hepatitis B Virus Reactivation in Lung Transplant Recipients with Previous Resolved Infection	16
New Rules, Improved Results: Successful Outcomes Bridging Patients Listed Status 1 for Heart Transplantation	16
A rare case of late onset tacrolimus-induced leukoencephalopathy and coma after pediatric orthotopic heart transplantation	16
DCD heart transplantation with NRP: Excellent results and a continued uphill battle	16
The human cytomegalovirus-specific and UL40-mediated imprint in the natural killer cell repertoire is associated with antibody-mediated rejection in lung transplant recipients	16
Normothermic Ex Vivo Lung Perfusion (Novel) as an Assessment of Extended Criteria Donor Lungs: A Prospective Multi-Center Clinical Trial	16
Enhancing Post-Lung Transplant Care with AlloHome: Early Impact Evaluation	16
“Durable left ventricular assist devices as a bridge to transplantation in The Old and The New World”	16
Letter to the Editor: Can the grading of mild cardiac allograft vasculopathy be further refined? An angiographic and physiologic assessment of heart transplant recipients with ISHLT CAV 1	16
Do Temporary Mechanical Circulatory Support Devices Activate Sensitization Pathways in Patients Awaiting Heart Transplantation?	16
Kidney function assessment using cystatin C and serum creatinine in heart transplantation recipients: Implications for valganciclovir dosing	16
Pulmonary artery fresh floating thrombus in patients with chronic thromboembolic pulmonary hypertension on low-dose direct oral anticoagulants: A single-center angiographic observational study	15
Pseudomonas-dominant microbiome elicits sustained IL-1β upregulation in alveolar macrophages from lung transplant recipients	15
Proteomic profiling identifies CLEC4C expression as a novel biomarker of primary graft dysfunction after heart transplantation	15
Table of Contents	15
Kratom Toxicity: A Mimicker of Fulminant Myocarditis	15
Shock Teams Grow Volume and Improve Outcomes in Cardiogenic Shock	15
Microcirculation as a Predictor of Clinical Outcomes in Left Ventricular Assist Device Therapy	15
Donor heart ischemic time can be extended beyond 9 hours using hypothermic machine perfusion in sheep	15
Impact of coronary hypoperfusion during agonal phase on outcomes following donation after circulatory death heart transplantation	15
Re-evaluating Ischemic Tolerance and Prognostic Accuracy in DCD Cardiac Transplantation: A Critical Appraisal of taNRP Outcomes	15
Towards a nuanced understanding of donor risk	15
WITHDRAWN	15
Early Rejection and Graft Vasculopathy in DCD Hearts: A Comparison of Recovery Methods	15
Evaluating Postoperative Outcomes of Heart Transplant Recipients from Active COVID19 Positive and Negative Donors Using Induction Therapy	15
Does Donor-Recipient Age Mismatch Affect Long-Term Immunological Outcomes? A 10-Year Single Center Study	15
Center volume effect on acute cellular rejection and outcomes in pediatric lung transplant recipients	15
Determining the impact of ex-vivo lung perfusion on hospital costs for lung transplantation: A retrospective cohort study	15
Functional status predicts pediatric heart transplant outcomes: A united network for organ sharing (UNOS) database study	15
Lung transplantation following donation after thoraco-abdominal normothermic regional perfusion (TA-NRP): A feasibility case study	15
Initial Analysis of Immune Phenotypes in Heart Transplant Recipients of the ALL IN HEART (Tocilizumab) Trial	15
Current Global Trends and Challenges Utilizing Pediatric Ventricular Assist Devices: An Action Collaborative Survey	15
Combination Approach of Perioperative Plasmapheresis and Eculizumab for Highly Sensitized Lung Transplant Patients	15
Durable Ventricular Assist Device Support with Systemic Right Ventricle Cannulation	15
Plasmablastic Lymphoma in a Lung Transplant Recipient	14
A Rare Case of HeartMate 3 Pump Stoppage	14
Use of Newer Intravascular Microaxial Ambulatory Left Ventricular Assist Devices as a Bridging Strategy for Cardiogenic Shock in Adult Congenital Heart Disease Patients	14
Donor Heart Preservation at 4-8°C Using Moderate Hypothermic Donor Heart Preservation Improves 4-year Survival in the US Guardian-Heart Registry	14
Left Ventricular Stenting - A Novel Technique for LVAD Implantation in Patients with Restrictive Cardiomyopathy	14
Long-Term Outcomes of Ventricular Assist Devices in Obese Pediatric Patients: An ACTION Registry Study	14
Differences in Prevention, Diagnosis, Surveillance and Treatment of Cardiac Allograft Vasculopathy in Heart Transplant Patients: Results of an International Survey	14
Impact of Preoperative Opioid Use in Lung Transplant Recipients	14
Porcine Mitochondria Transplantation in Human iPS-Cardiomyocytes and Intact Hearts	14
Patients with Acute Lung Rejection Have a Worse Outcome After Combined Heart-Lung Transplantation	14
Esophagogastric Junction (EGJ) Outflow Obstruction is Associated with Chronic Lung Allograft Dysfunction (CLAD)	14
Use and Outcomes of Ex-Vivo Machine Perfusion (EVMP) in Donation After Brain Death (DBD) Heart Transplantation (HT)	14
Reversion of Val(ganciclovir)-Resistance Associated Mutation in Two SOT Patients with Mismatch Serostatus for CMV (D+/R-)	14
MHC Class II Matching Does Not Predict Survival in Organ and Bone Marrow Transplantation in Non-Human Primates	14
Application of Optical Mapping for Assessing Ischemic Regions in Donor Hearts: A Novel Approach to Monitoring Action Potential Hysteresis and Triangulation	14
Tuberculosis Post Lung Transplantation - An Indian Experience	14
Hemodynamics at Submaximal Exercise Independently Predict Outcomes in Severe Heart Failure	14
First Sub-Zero Cardiac Allograft Preservation and Reanimation Following 24-Hours of Isochoric Supercooled Preservation	14
Does Gastrointestinal Bleeding Increase the Risk of Thromboembolic Events in Patients Supported with CF-LVADs?	14
Improving Efficiency in Pharmacist Led Thoracic Transplant Patient Medication Education	14
Gut Reaction: Gastroesophageal Reflux Fuels De Novo DSA Development After Lung Transplant	14
Non-Ischemic Preservation of the Donor Heart in Heart Transplantation - A Randomized, Controlled, Multicenter Trial Using The Xvivo Heart Assist Preservation System for Hypothermic Oxygenated Perfusio	13
Outcomes of Explanted LVAD Patients with Heart Failure Relapse Requiring Heart Replacement Therapies: A VAD Wean Registry Analysis	13
Lung Ultrasound for Diagnosis of Primary Graft Dysfunction in Lung Transplantation Recipients	13
Donor sequence number is not associated with worse lung transplant outcomes regardless of transplant center case volume	13
ADAM10-Mediated VE-Cadherin Shedding May Increase the Risk of Sepsis for Heart Failure Patients Supported by Continuous-Flow Left Ventricular Assist Devices	13
Barriers and opportunities in donation after circulatory death heart transplantation	13
Dapagliflozin Use in Children with Heart Failure Undergoing Heart Transplantation	13
Clinical impact of TERT somatic mutation in telomerase-related gene mutation carriers after lung transplantation	13
The Impact of Functional Warm Ischemia Time on Procurement and Preservation Technique in DCD Heart Transplantation	13
Donor-Derived Cell-Free DNA as a Biomarker for the Effect of Daratumumab in Patients with Antibody-Mediated Rejection Post-Heart Transplant	13
CD38 Antibody Daratumumab as an Add-On Rescue Therapy for AMR - First Report in Clinical Lung Transplantation	13
Early posttransplant reductions in club cell secretory protein associate with future risk for chronic allograft dysfunction in lung recipients: results from a multicenter study	13
SAFETY OF BALLOON PULMONARY ANGIOPLASTY IN CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	12
Axillary Temporary Mechanical Circulatory Support to Bridge Cardiogenic Shock Patients to Heart Transplantation	12
Impact of Innate Rejection on Graft Survival in Heart Transplantation: Preliminary Findings on Missing-Self Induced Microvascular Rejection	12
Triheptanoin Use for Severe Neonatal Cardiomyopathy Secondary to Mitochondrial Trifunctional Protein Deficiency- A First Report	12
Digoxin Reverses Angiogenic Dysregulation During HeartMate 3 Support by Inhibiting the HIF1-a Signaling Cascade and is Associated with Decreased Risk for Gastrointestinal Bleeding	12
Influence of Environmental Temperature on the Occurrence of Driveline Infection in LVAD Patients	12
Deglycosylation of Lung Reactive Autoantibodies Ameliorates Graft Injury Post Lung Transplant	12
Clinician Assessed Versus Objective Measures of Frailty in Left Ventricular Assist Device Patients	12
Impact of evolocumab on coronary physiology and microstructure in de-novo heart transplant recipients	12
Identification and Clinical Course of Novel Pathogenic Variant of Transthyretin Amyloid Cardiomyopathy: P.arg54lys	12
Incorporating Donor Variables Improves Accuracy of One-Year Post-Transplant Survival Prediction for Adult Heart Transplant Recipients	12
Coronavirus disease 2019 outcomes in heart transplant recipients: A large Australian cohort	12
Safety of Sodium Glucose Co-Transporter 2 Inhibitor Exposure Prior to Heart Transplantation	12
Absent Sounds: Use of Haptic Devices for LVAD Alarms in a Patient with Hearing Loss	11
A Case Series of Gastrointestinal Bleeding Related to Arteriovenous Malformations with Impella 5.5	11
Estimating Prognosis Among Advanced Heart Failure Patients Referred for Advanced Heart Failure Therapies at the University Health Network	11
Enhancing Exercise Capacity in Exercise-Induced Pulmonary Hypertension: A Retrospective Study of Riociguat Therapy	11
Donor Chimerism Duration Correlates with Heart Allograft Tolerance in Combined Heart and Bone Marrow Transplantation in Nonhuman Primates	11
Characterization and Treatment of Iron Deficiency in Left Ventricular Assist Device Patients	11
The cGAS-Sting Pathway Drives Alveolar Epithelial Cell Death via Non-Canonical PKR Signaling During Lung Ischemia-Reperfusion Injury	11
Outcomes in Patients with Acute Cellular Rejection Grade 1R: Is the Debate Over?	11
Days Alive out of the Hospital After Placement of A Contemporary Left Ventricular Assist Device and Heart Transplantation	11
Heart Transplant Outcomes in Higher Risk Recipients	11
BAL-EVs from Lung Transplanted Patients are of Leukocytic Origin and Activates IL17 Pathway in Respiratory Cells	11
Pump Supporting a Pump- Trials and Tribulations!	11